Brian Diskin

Brian Diskin

Auto-generated profile, based on publicly available information

Brian Diskin

S. Arthur Localio Laboratory, Department of Surgery, New York University School of Medicine, NYU Langone Health, New York, NY 4

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CFCarmine Fedele
Carmine Fedele
SLShuai Li
Shuai Li
KTKai Wen Teng
Kai Wen Teng
CFConnor J.R. Foster
Connor J.R. Foster
DPDavid Peng
David Peng
BNBenjamin G. Neel
Benjamin G. Neel
KRAS is the most frequently mutated human oncogene, and KRAS inhibition has been a longtime goal. Recently, inhibitors were developed that bind KRASG12C-GDP and react with Cys-12 (G12C-Is). Using new affinity reagents to monitor KRASG12C activation and inhibitor engagement, we found that an SHP2 inhibitor (SHP2-I) increases KRAS-GDP occupancy, enhancing G12C-I efficacy. The SHP2-I abrogated RTK feedback signaling and adaptive resistance to G12C-Is in vitro, in xenografts, and in syngeneic KRASG12C-mutant pancreatic ductal adenocarcinoma (PDAC) and non–small cell lung cancer (NSCLC). SHP2-I/G12C-I combination evoked favorable but tumor site–specific changes in the immune microenvironment, decreasing myeloid suppressor cells, increasing CD8+ T cells, and sensitizing tumors to PD-1 blockade. Experiments using cells expressing inhibitor-resistant SHP2 showed that SHP2 inhibition in PDAC cells is required for PDAC regression and remodeling of the immune microenvironment but revealed direct inhibitory effects on tumor angiogenesis and vascularity. Our results demonstrate that SHP2-I/G12C-I combinations confer a substantial survival benefit in PDAC and NSCLC and identify additional potential combination strategies.

1 October 2014 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
NSNimrod Snir
Nimrod Snir
RSRan Schwarzkopf
Ran Schwarzkopf
BDBrian Diskin
Brian Diskin
RTRichelle Takemoto
Richelle Takemoto
MHMathew Hamula
Mathew Hamula
PMPatrick A. Meere
Patrick A. Meere




3 April 2023
Verified
Other
Open access
CFCarmine Fedele
Carmine Fedele
HRHao Ran
Hao Ran
BDBrian Diskin
Brian Diskin
WWWei Wei
Wei Wei
JJJayu Jen
Jayu Jen
KTKwan Ho Tang
Kwan Ho Tang
Supplementary table and figure legends